Parsey Merdad has filed 71 insider transactions across 4 companies since December 2022.
Most recent transaction: a grant/award of 15235 shares of ARDELYX, INC. ($ARDX) on June 18, 2025.
Activity breakdown: 0 open-market purchases and 18 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 18, 2025 | ARDELYX, INC. | $ARDX | Parsey Merdad | Director | A | Common Stock | 15235 | $0.00 | 57,291.0000 | 238,356,222 | 36.23% | 0.01% |
| June 18, 2025 | ArriVent BioPharma, Inc. | $AVBP | Parsey Merdad | Director | A | Non-Qualified Stock Option (right to buy) | 15502 | $0.00 | 15,502.0000 | 33,898,870 | 9999.99% | 0.05% |
| April 28, 2025 | ARDELYX, INC. | $ARDX | Parsey Merdad | Director | A | Stock Option (Right to Buy) | 64457 | $0.00 | 64,457.0000 | 238,356,222 | 9999.99% | 0.03% |
| April 28, 2025 | ARDELYX, INC. | $ARDX | Parsey Merdad | Director | A | Common Stock | 42056 | $0.00 | 42,056.0000 | 238,356,222 | 9999.99% | 0.02% |
| April 28, 2025 | ArriVent BioPharma, Inc. | $AVBP | Parsey Merdad | Director | A | Stock Option (right to buy) | 28346 | $0.00 | 28,346.0000 | 33,898,870 | 9999.99% | 0.08% |
| Dec. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 3820 | $0.00 | 36,753.0000 | 1,254,000,000 | 9.42% | 0.00% |
| Dec. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | F | Common Stock | 1771 | $92.34 | 82,850.0000 | 1,254,000,000 | 2.09% | 0.00% |
| Dec. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Common Stock | 3820 | $0.00 | 84,621.0000 | 1,254,000,000 | 4.73% | 0.00% |
| Nov. 27, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | S | Common Stock | 57294 | $91.79 | 187,718.0000 | 1,254,000,000 | 23.38% | 0.00% |
| Nov. 27, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | S | Common Stock | 88119 | $92.00 | 99,599.0000 | 1,254,000,000 | 46.94% | 0.01% |
| Nov. 27, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | S | Common Stock | 5200 | $91.80 | 94,399.0000 | 1,254,000,000 | 5.22% | 0.00% |
| Nov. 27, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | S | Common Stock | 3199 | $91.80 | 91,200.0000 | 1,254,000,000 | 3.39% | 0.00% |
| Nov. 27, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | S | Common Stock | 10399 | $92.00 | 80,801.0000 | 1,254,000,000 | 11.40% | 0.00% |
| Nov. 27, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Non-qualified Stock Option (Right to Buy) | 57294 | $0.00 | 64,376.0000 | 1,254,000,000 | 47.09% | 0.00% |
| Nov. 27, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Non-qualified Stock Option (Right to Buy) | 88119 | $0.00 | 196.0000 | 1,254,000,000 | 99.78% | 0.01% |
| Nov. 27, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Common Stock | 57294 | $57.92 | 156,893.0000 | 1,254,000,000 | 57.52% | 0.00% |
| Nov. 27, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Common Stock | 88119 | $65.38 | 245,012.0000 | 1,254,000,000 | 56.17% | 0.01% |
| Nov. 6, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | S | Common Stock | 5000 | $91.50 | 99,599.0000 | 1,254,000,000 | 4.78% | 0.00% |
| Nov. 6, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Non-qualified Stock Option (Right to Buy) | 25000 | $0.00 | 121,670.0000 | 1,254,000,000 | 17.05% | 0.00% |
| Nov. 6, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Common Stock | 25000 | $57.92 | 125,189.0000 | 1,254,000,000 | 24.95% | 0.00% |
| Nov. 6, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | S | Common Stock | 20590 | $91.50 | 104,599.0000 | 1,254,000,000 | 16.45% | 0.00% |
| Oct. 1, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | S | Common Stock | 2000 | $83.83 | 100,189.0000 | 1,254,000,000 | 1.96% | 0.00% |
| Sept. 12, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Non-qualified Stock Option (Right to Buy) | 25000 | $0.00 | 146,670.0000 | 1,258,000,000 | 14.56% | 0.00% |
| Sept. 12, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | S | Common Stock | 21246 | $84.50 | 102,189.0000 | 1,258,000,000 | 17.21% | 0.00% |
| Sept. 12, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Common Stock | 25000 | $57.92 | 123,435.0000 | 1,258,000,000 | 25.40% | 0.00% |
| Sept. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 3821 | $0.00 | 40,573.0000 | 1,258,000,000 | 8.61% | 0.00% |
| Sept. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Common Stock | 3821 | $0.00 | 100,201.0000 | 1,258,000,000 | 3.96% | 0.00% |
| Sept. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | F | Common Stock | 1766 | $81.44 | 98,435.0000 | 1,258,000,000 | 1.76% | 0.00% |
| July 1, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | S | Common Stock | 2000 | $68.63 | 96,380.0000 | 1,258,000,000 | 2.03% | 0.00% |
| June 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Common Stock | 3820 | $0.00 | 100,124.0000 | 1,258,000,000 | 3.97% | 0.00% |
| June 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | F | Common Stock | 1744 | $65.25 | 98,380.0000 | 1,258,000,000 | 1.74% | 0.00% |
| June 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 3820 | $0.00 | 44,394.0000 | 1,258,000,000 | 7.92% | 0.00% |
| June 5, 2024 | Sagimet Biosciences Inc. | $SGMT | Parsey Merdad | Director | A | Stock Option (Right to Buy) | 51459 | $0.00 | 51,459.0000 | 29,039,427 | 9999.99% | 0.18% |
| April 1, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | S | Common Stock | 2000 | $72.96 | 96,304.0000 | 1,258,000,000 | 2.03% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | A | Non-qualified Stock Option (Right to Buy) | 89660 | $0.00 | 89,660.0000 | 1,258,000,000 | 9999.99% | 0.01% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | A | Restricted Stock Unit | 17640 | $0.00 | 48,214.0000 | 1,258,000,000 | 57.70% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 3455 | $0.00 | 37,520.0000 | 1,258,000,000 | 8.43% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 6946 | $0.00 | 30,574.0000 | 1,258,000,000 | 18.51% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | F | Common Stock | 4803 | $75.12 | 98,304.0000 | 1,258,000,000 | 4.66% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Common Stock | 3455 | $0.00 | 96,161.0000 | 1,258,000,000 | 3.73% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Common Stock | 6946 | $0.00 | 103,107.0000 | 1,258,000,000 | 7.22% | 0.00% |
| Feb. 28, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | S | Common Stock | 2000 | $73.18 | 100,936.0000 | 1,258,000,000 | 1.94% | 0.00% |
| Feb. 29, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | S | Common Stock | 8230 | $72.74 | 92,706.0000 | 1,258,000,000 | 8.15% | 0.00% |
| Jan. 31, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | A | Common Stock | 56624 | $0.00 | 126,325.0000 | 1,258,000,000 | 81.24% | 0.00% |
| Jan. 31, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | A | Common Stock | 20229 | $0.00 | 69,701.0000 | 1,258,000,000 | 40.89% | 0.00% |
| Jan. 31, 2024 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | F | Common Stock | 23709 | $78.26 | 102,616.0000 | 1,258,000,000 | 18.77% | 0.00% |
| Dec. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Common Stock | 2779 | $0.00 | 72,909.0000 | 1,262,000,000 | 3.96% | 0.00% |
| Dec. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | F | Common Stock | 1269 | $79.02 | 71,640.0000 | 1,262,000,000 | 1.74% | 0.00% |
| Dec. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 2779 | $0.00 | 40,975.0000 | 1,262,000,000 | 6.35% | 0.00% |
| Sept. 12, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | S | Common Stock | 1501 | $76.99 | 70,130.0000 | 1,262,000,000 | 2.10% | 0.00% |
| Sept. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | F | Common Stock | 1278 | $76.00 | 71,631.0000 | 1,262,000,000 | 1.75% | 0.00% |
| Sept. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Common Stock | 2779 | $0.00 | 72,909.0000 | 1,262,000,000 | 3.96% | 0.00% |
| Sept. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 2779 | $0.00 | 43,754.0000 | 1,262,000,000 | 5.97% | 0.00% |
| June 13, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | S | Common Stock | 1485 | $76.90 | 29,402.0000 | 1,262,000,000 | 4.81% | 0.00% |
| June 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Common Stock | 2779 | $0.00 | 32,181.0000 | 1,262,000,000 | 9.45% | 0.00% |
| June 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | F | Common Stock | 1294 | $78.12 | 30,887.0000 | 1,262,000,000 | 4.02% | 0.00% |
| June 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 2779 | $0.00 | 46,533.0000 | 1,262,000,000 | 5.64% | 0.00% |
| March 13, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | S | Common Stock | 6126 | $78.99 | 70,130.0000 | 1,262,000,000 | 8.03% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Common Stock | 3455 | $0.00 | 73,585.0000 | 1,262,000,000 | 4.93% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Common Stock | 7999 | $0.00 | 81,584.0000 | 1,262,000,000 | 10.87% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | F | Common Stock | 5328 | $79.50 | 76,256.0000 | 1,262,000,000 | 6.53% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 3455 | $0.00 | 40,646.0000 | 1,262,000,000 | 7.83% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 7999 | $0.00 | 32,647.0000 | 1,262,000,000 | 19.68% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | A | Restricted Stock Unit | 16665 | $0.00 | 49,312.0000 | 1,262,000,000 | 51.05% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | A | Non-qualified Stock Option (Right to Buy) | 76000 | $0.00 | 76,000.0000 | 1,262,000,000 | 9999.99% | 0.01% |
| March 1, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | S | Common Stock | 12984 | $79.96 | 70,130.0000 | 1,262,000,000 | 15.62% | 0.00% |
| Feb. 15, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | A | Common Stock | 376 | $56.38 | 83,114.0000 | 1,262,000,000 | 0.45% | 0.00% |
| Jan. 24, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | A | Common Stock | 29644 | $0.00 | 56,772.0000 | 1,262,000,000 | 109.27% | 0.00% |
| Jan. 24, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | A | Common Stock | 43715 | $0.00 | 100,487.0000 | 1,262,000,000 | 77.00% | 0.00% |
| Jan. 24, 2023 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | F | Common Stock | 17749 | $84.02 | 82,738.0000 | 1,262,000,000 | 17.66% | 0.00% |
| Dec. 30, 2022 | GILEAD SCIENCES, INC. | $GILD | Parsey Merdad | Chief Medical Officer | S | Common Stock | 553 | $85.33 | 45,556.0000 | 0 | 1.20% | 0.00% |